RIPK3 and acute myeloid leukemia: Hence, RIPK3 expression is downregulated in many cancer cell lines [18,123] as well as in several human cancers, including breast cancer [18], colorectal cancer (CRC) [17], acute myeloid leukemia (AML) [124] and melanoma [123].